Filters
Children with early-onset atopic dermatitis (AD) face an increased risk of uveitis, as reported in a study.
New drug applications approved by US FDA as of 16-31 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Children exposed to HIV but uninfected appear to have an initial growth deficit at birth that persists for at least the first 24 months of life, according to a meta-analysis.
Prenatal exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) has the potential to harm the offspring’s kidney health, highlighting the need for caution when prescribing NSAIDs during pregnancy, according to a large study from Taiwan.
Exposure to relatively low ambient ozone at ground level (O3) during early life appears to carry an increased risk of asthma and wheeze outcomes at age 4–6 years, as reported in a study.
Wipes formulated with purified water plus fruit extract for sensitive skin are safe to use on babies with eczema-prone skin or active eczema, according to a study.
Physical activity, outdoor play, and reading books boost children's cognitive development, but excess physical activity may harm academic performance if it cuts into sleep time, as shown in a study from Singapore.
Around 40 percent of children who have undergone a surgical procedure for complicated appendicitis can be safely sent home for recovery, as shown in a pilot study.
New drug applications approved by US FDA as of 1-15 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Preterm and very low birthweight (VLBW) infants who have been treated with ganciclovir (GCV) or oral valganciclovir (valGCV) for cytomegalovirus (CMV) disease are more likely to experience adverse events than term infants, a study has shown.
